Kempharm Inc buy Quitte
Start price
15.06.16
/
50%
€4.26
Target price
15.12.16
€4.73
Performance (%)
-27.97%
End price
15.12.16
€3.07
Summary
This prediction ended on 15.12.16 with a price of €3.07. The prediction for Kempharm Inc disappointed with a performance of -27.97%. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Kempharm Inc | - | - | - | - |
iShares Core DAX® | -0.598% | 0.645% | 10.813% | 15.396% |
iShares Nasdaq 100 | -3.290% | -4.193% | 23.772% | 40.773% |
iShares Nikkei 225® | -0.796% | -0.582% | 8.390% | 8.288% |
iShares S&P 500 | -1.164% | -0.857% | 23.003% | 41.152% |
Comments by Quitte for this prediction
In the thread Kempharm Inc diskutieren
nach dem Absturz ist vor dem Anstieg
Shares of KemPharm Inc. (KMPH) were down over 26% in extended trading on Monday, following the receipt of FDA's complete response letter for the company's New drug Application for Apadaz.
(Laufzeit überschritten)